• ABOUT
  • THE GROUP
  • NEWS & MEDIA
  • EVENTS
  • CAREER
  • CONTACT US
  • 0

Abbott RealTime HCV Assay

Abbott RealTime HCV Assay
The Abbott RealTime HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of hepatitis C viral ribonucleic acid (HCV RNA) in human serum and plasma from HCV-infected individuals.
Read More
Add to Shortlist

Features & Benefits

  • Enhanced precision – providing confidence in deciding whether to stop, shorten or extend drug therapy
  • Improved sensitivity – Accurate monitoring of even low viral loads to enable early detection of changes to patient response status
  • Accurate detection of genotypes 1– 6 – Assuring confidence in quantitative results, regardless of genotype

Product Details

The Abbott RealTime HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of hepatitis C viral ribonucleic acid (HCV RNA) in human serum and plasma from HCV-infected individuals. The Abbott RealTime HCV assay is intended for use as an aid in the management of HCV-infected patients undergoing antiviral therapy.



Abbott RealTime HCV is engineered to quantify all HCV genotypes (1–6) equally and provide sensitivity, specificity, and dynamic range to meet your laboratory needs.


Accurate quantification is dependent upon a combination of:



  • Primer design

  • Probe design

  • Cycling conditions

Read More